QIAGEN Quick Ratio 2010-2023 | QGEN
Historical quick ratio values for QIAGEN (QGEN) over the last 10 years.
| QIAGEN Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2023-03-31 |
$1.87B |
$0.89B |
2.10 |
| 2022-12-31 |
$2.04B |
$0.98B |
2.09 |
| 2022-09-30 |
$2.43B |
$1.50B |
1.62 |
| 2022-06-30 |
$1.82B |
$0.96B |
1.89 |
| 2022-03-31 |
$1.78B |
$0.96B |
1.86 |
| 2021-12-31 |
$1.78B |
$1.52B |
1.17 |
| 2021-09-30 |
$1.69B |
$1.07B |
1.58 |
| 2021-06-30 |
$1.46B |
$0.50B |
2.90 |
| 2021-03-31 |
$1.35B |
$0.50B |
2.70 |
| 2020-12-31 |
$1.33B |
$0.57B |
2.33 |
| 2020-09-30 |
$1.33B |
$1.09B |
1.22 |
| 2020-06-30 |
$1.43B |
$0.96B |
1.50 |
| 2020-03-31 |
$1.41B |
$1.00B |
1.42 |
| 2019-12-31 |
$1.40B |
$0.95B |
1.47 |
| 2019-09-30 |
$1.37B |
$0.63B |
2.18 |
| 2019-06-30 |
$1.45B |
$0.91B |
1.59 |
| 2019-03-31 |
$1.43B |
$0.94B |
1.52 |
| 2018-12-31 |
$1.99B |
$0.97B |
2.05 |
| 2018-09-30 |
$1.71B |
$1.37B |
1.25 |
| 2018-06-30 |
$1.53B |
$0.94B |
1.63 |
| 2018-03-31 |
$1.59B |
$0.82B |
1.94 |
| 2017-12-31 |
$1.49B |
$0.33B |
4.59 |
| 2017-09-30 |
$1.41B |
$0.30B |
4.78 |
| 2017-06-30 |
$1.00B |
$0.30B |
3.34 |
| 2017-03-31 |
$0.62B |
$0.27B |
2.26 |
| 2016-12-31 |
$0.90B |
$0.31B |
2.92 |
| 2016-09-30 |
$0.82B |
$0.25B |
3.27 |
| 2016-06-30 |
$0.76B |
$0.25B |
3.06 |
| 2016-03-31 |
$0.81B |
$0.25B |
3.31 |
| 2015-12-31 |
$0.83B |
$0.27B |
3.07 |
| 2015-09-30 |
$0.84B |
$0.28B |
3.04 |
| 2015-06-30 |
$0.79B |
$0.27B |
2.98 |
| 2015-03-31 |
$0.82B |
$0.33B |
2.47 |
| 2014-12-31 |
$1.02B |
$0.43B |
2.36 |
| 2014-09-30 |
$1.14B |
$0.44B |
2.61 |
| 2014-06-30 |
$1.07B |
$0.30B |
3.60 |
| 2014-03-31 |
$1.08B |
$0.31B |
3.45 |
| 2013-12-31 |
$0.79B |
$0.34B |
2.35 |
| 2013-09-30 |
$0.73B |
$0.30B |
2.41 |
| 2013-06-30 |
$0.77B |
$0.30B |
2.59 |
| 2013-03-31 |
$0.85B |
$0.27B |
3.17 |
| 2012-12-31 |
$0.86B |
$0.27B |
3.21 |
| 2012-09-30 |
$0.66B |
$0.54B |
1.22 |
| 2012-06-30 |
$0.60B |
$0.51B |
1.18 |
| 2012-03-31 |
$0.63B |
$0.45B |
1.38 |
| 2011-12-31 |
$0.61B |
$0.45B |
1.36 |
| 2011-09-30 |
$0.83B |
$0.65B |
1.28 |
| 2011-06-30 |
$1.27B |
$0.37B |
3.47 |
| 2011-03-31 |
$1.26B |
$0.38B |
3.35 |
| 2010-12-31 |
$1.24B |
$0.39B |
3.19 |
| 2010-09-30 |
$1.22B |
$0.40B |
3.09 |
| 2010-06-30 |
$1.24B |
$0.32B |
3.84 |
| 2010-03-31 |
$1.21B |
$0.34B |
3.57 |
| 2009-12-31 |
$1.20B |
$0.38B |
3.20 |
| 2009-09-30 |
$1.24B |
$0.38B |
3.29 |
| 2009-06-30 |
$0.67B |
$0.26B |
2.52 |
| 2009-03-31 |
$0.60B |
$0.22B |
2.68 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$10.347B |
$2.142B |
|
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
|
